The stock is a quality value proposition at this price point. It trades similar to many biotechs. ONCS has the makings of a great company and stock investment. Good news is anticipated with the upcoming medical conferences and of course savvy investors will be buying in prior to the news release.
this stock is up 50% and holding in one week. You guys are asking it to never retrace. No stock that I know hold all its gains. It raises. It has people that take profit and it consolidates its gains. If ONCS stays above 33 for the next week I for one will be a very happy shareholder. Do I hope it runs higher? Yes. But it needs to be given time. This is a great idea. A lot of cancer is going to be treated by this process. This stock is a proven winner. Give it time.